Biological Industries

Tissue Culture Products for Research and Diagnostics

Health Tech & Life Sciences
Acquired by Sartorius on May, 2019

Company Overview

Snapshot

Founded in December 1990, Biological Industries operates with 51–200 employees. The company was acquired by Sartorius in May 2019, marking a significant milestone in its trajectory within the life sciences industry.

Business overview

Biological Industries is a global supplier to the life sciences industry, specializing in cell culture media development and manufacturing. The company provides cell culture media, supplements, and reagents for stem cell research, potential cell therapy applications, and serum-free media. It serves the biopharmaceutical industry, universities, government research organizations, and healthcare institutions, operating within the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology and Medical Devices.

Strategic signal

In December 2019, Sartorius acquired a majority stake in Biological Industries, a strategic move that integrated Biological Industries' expertise in cell culture media into Sartorius's portfolio. This acquisition signals a consolidation within the life sciences tools market, enhancing Sartorius's offerings in cell culture and bioprocessing, and providing Biological Industries with expanded resources and market reach.

Company Intelligence Q&A

What is Biological Industries' primary focus?
Biological Industries is a global supplier for the life sciences industry, specializing in the development and manufacturing of cell culture media, supplements, and reagents for research and diagnostics.
When was Biological Industries acquired?
Biological Industries was acquired by Sartorius in May 2019.
What products does Biological Industries offer?
Biological Industries offers a range of products including cell culture media, supplements, reagents for stem cell research and cell therapy applications, and serum-free media such as NutriFreez, MSCgo, and NutriStem.
Which industries does Biological Industries serve?
Biological Industries supplies life science products to the biopharmaceutical industry, universities, government research organizations, and healthcare institutions globally.
Did Biological Industries USA sign any significant agreements in 2017?
In March 2017, Biological Industries USA signed an agreement with Mill Creek Life Sciences to add PLTMax Human Platelet Lysate to its stem cell portfolio.

External links